Idexx Laboratories
IDXX
1,154 hedge funds and large institutions have $40.8B invested in Idexx Laboratories in 2023 Q4 according to their latest regulatory filings, with 190 funds opening new positions, 351 increasing their positions, 423 reducing their positions, and 81 closing their positions.
135% more first-time investments, than exits
New positions opened: 190 | Existing positions closed: 81
38% more funds holding in top 10
Funds holding in top 10: 21 → 29 (+8)
26% more capital invested
Capital invested by funds: $32.4B → $40.8B (+$8.39B)
9% more funds holding
Funds holding: 1,059 → 1,154 (+95)
9% more call options, than puts
Call options by funds: $125M | Put options by funds: $115M
0.63% less ownership
Funds ownership: 89.15% → 88.52% (-0.63%)
17% less repeat investments, than reductions
Existing positions increased: 351 | Existing positions reduced: 423
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$225M |
| 2 |
BlackRock
New York
|
+$197M |
| 3 |
Millennium Management
New York
|
+$141M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$115M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$78.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$407M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$182M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$154M |
| 4 |
ESCM
Echo Street Capital Management
New York
|
-$111M |
| 5 |
Fundsmith LLP
London,
United Kingdom
|
-$111M |
IDXX Hedge Fund Activity: Q4 2023 in Review
1,154 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2023, worth a combined $40.8B — up 26% from $32.4B a quarter earlier.
Buyers outnumbered sellers: 190 funds opened new IDXX positions and 81 closed out — a net gain of 109 holders — while 351 added to existing stakes and 423 trimmed.
The largest buyer was Neuberger Berman Group, adding an estimated $225M. The largest seller was GQG Partners, exiting entirely with an estimated $407M sold.
- 1,154 institutional investors held Idexx Laboratories (IDXX) as of Q4 2023, up from 1,059 in Q3 2023.
- Funds reported $40.8B of Idexx Laboratories stock for Q4 2023, up 26% quarter-over-quarter.
- 190 funds opened new Idexx Laboratories positions in Q4 2023 and 81 closed out, a net change of +109 holders.
- The largest Idexx Laboratories buyer in Q4 2023 was Neuberger Berman Group, an estimated $225M added.
- The largest Idexx Laboratories seller in Q4 2023 was GQG Partners, an estimated $407M sold.
Based on aggregated 13F filings for Q4 2023.